Terms: = Lymphoma AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL
37 results:
1. t(10;12)(q24;q15): A new cytogenetic marker in hematological malignancies.
Bernués M; González T; Corchete LA; Santos S; Durán MA; López-Andrade B; Riso LL; Martínez-Serra J; Ramos R; Iglesias J; Royo I; Rosell J
Cancer Genet; 2022 Jun; 264-265():60-65. PubMed ID: 35397254
[TBL] [Abstract] [Full Text] [Related]
2. Effects of
Chen Q; Fu Q; Pu L; Liu X; Liu Y
J Int Med Res; 2022 Feb; 50(2):3000605221075511. PubMed ID: 35118889
[TBL] [Abstract] [Full Text] [Related]
3. Critical role of the high mobility group A proteins in hematological malignancies.
De Martino M; Esposito F; Fusco A
Hematol Oncol; 2022 Feb; 40(1):2-10. PubMed ID: 34637548
[TBL] [Abstract] [Full Text] [Related]
4. Reversible switching of primary cells between normal and malignant state by oncogenic virus KSHV and CRISPR/Cas9-mediated targeting of a major viral latent protein.
Ju E; Li T; Ramos da Silva S; Markazi A; Gao SJ
J Med Virol; 2021 Aug; 93(8):5065-5075. PubMed ID: 33942339
[TBL] [Abstract] [Full Text] [Related]
5. Combination immunotherapy of oncolytic virus nanovesicles and PD-1 blockade effectively enhances therapeutic effects and boosts antitumour immune response.
Ji W; Li L; Zhou S; Qiu L; Qian Z; Zhang H; Zhao P
J Drug Target; 2020 Nov; 28(9):982-990. PubMed ID: 32379004
[TBL] [Abstract] [Full Text] [Related]
6. Risk Factors for Early Mortality in Patients with Primary Central Nervous System lymphoma: A Large-Cohort Retrospective Study.
Zhou X; Niu X; Li J; Zhang S; Yang W; Yang Y; Mao Q; Liu Y
World Neurosurg; 2020 Jun; 138():e905-e912. PubMed ID: 32251807
[TBL] [Abstract] [Full Text] [Related]
7. MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.
Takashima Y; Kawaguchi A; Iwadate Y; Hondoh H; Fukai J; Kajiwara K; Hayano A; Yamanaka R
PLoS One; 2019; 14(1):e0210400. PubMed ID: 30615673
[TBL] [Abstract] [Full Text] [Related]
8. Vincristine-Loaded and sgc8-Modified liposome as a Potential Targeted Drug Delivery System for Treating Acute Lymphoblastic Leukemia.
Duan S; Yu Y; Lai C; Wang D; Wang Y; Xue D; Hu Z; Lu X
J Biomed Nanotechnol; 2018 May; 14(5):910-921. PubMed ID: 29883561
[TBL] [Abstract] [Full Text] [Related]
9. [Establishment and Identification of Mouse Model of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia].
Wang X; Qi N; Ma S; Song XG; Yan ZL; Wu QY; Wang L; Chen C; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1324-1328. PubMed ID: 27784350
[TBL] [Abstract] [Full Text] [Related]
10. Myeloproliferative neoplasms: Current molecular biology and genetics.
Saeidi K
Crit Rev Oncol Hematol; 2016 Feb; 98():375-89. PubMed ID: 26697989
[TBL] [Abstract] [Full Text] [Related]
11. hmga2 as a potential molecular target in KMT2A-AFF1-positive infant acute lymphoblastic leukaemia.
Wu Z; Eguchi-Ishimae M; Yagi C; Iwabuki H; Gao W; Tauchi H; Inukai T; Sugita K; Ishii E; Eguchi M
Br J Haematol; 2015 Dec; 171(5):818-29. PubMed ID: 26403224
[TBL] [Abstract] [Full Text] [Related]
12. The critical role of hmga2 in regulation of EMT in epithelial ovarian carcinomas.
Yan J; Zhang Y; Shi W; Ren C; Liu Y; Pan Y
Tumour Biol; 2016 Jan; 37(1):823-8. PubMed ID: 26250458
[TBL] [Abstract] [Full Text] [Related]
13. Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma.
Belletti D; Tosi G; Riva G; Lagreca I; Galliania M; Luppi M; Vandelli MA; Forni F; Ruozi B
Int J Pharm; 2015 Jul; 490(1-2):85-93. PubMed ID: 25987470
[TBL] [Abstract] [Full Text] [Related]
14. Searching for metastases in ovarian tissue before autotransplantation: a tailor-made approach.
Hoekman EJ; Smit VT; Fleming TP; Louwe LA; Fleuren GJ; Hilders CG
Fertil Steril; 2015 Feb; 103(2):469-77. PubMed ID: 25497447
[TBL] [Abstract] [Full Text] [Related]
15. Human hmga2 protein overexpressed in mice induces precursor T-cell lymphoblastic leukemia.
Efanov A; Zanesi N; Coppola V; Nuovo G; Bolon B; Wernicle-Jameson D; Lagana A; Hansjuerg A; Pichiorri F; Croce CM
Blood Cancer J; 2014 Jul; 4(7):e227. PubMed ID: 25014774
[TBL] [Abstract] [Full Text] [Related]
16. Gene expression profiling of non-hodgkin lymphomas.
Zekri AR; Hassan ZK; Bahnassy AA; Eldahshan DH; El-Rouby MN; Kamel MM; Hafez MM
Asian Pac J Cancer Prev; 2013; 14(7):4393-8. PubMed ID: 23992009
[TBL] [Abstract] [Full Text] [Related]
17. [liposomal cytarabine in prophylaxis of the central nervous system involvement in rare aggresive lymphomas].
Kumiega B; Jurczak W; Fornagiel S; Dzietczenia J; Skotnicki AB
Przegl Lek; 2013; 70(4):187-90. PubMed ID: 23991555
[TBL] [Abstract] [Full Text] [Related]
18. Screening for possible miRNA-mRNA associations in a colon cancer cell line.
Kanematsu S; Tanimoto K; Suzuki Y; Sugano S
Gene; 2014 Jan; 533(2):520-31. PubMed ID: 23939471
[TBL] [Abstract] [Full Text] [Related]
19. Effect of silencing of high mobility group A2 gene on gastric cancer MKN-45 cells.
Wei CH; Wei LX; Lai MY; Chen JZ; Mo XJ
World J Gastroenterol; 2013 Feb; 19(8):1239-46. PubMed ID: 23482887
[TBL] [Abstract] [Full Text] [Related]
20. MicroRNA (miRNA) expression profiling of peripheral blood samples in multiple myeloma patients using microarray.
Yyusnita ; Norsiah ; Zakiah I; Chang KM; Purushotaman VS; Zubaidah Z; Jamal R
Malays J Pathol; 2012 Dec; 34(2):133-43. PubMed ID: 23424776
[TBL] [Abstract] [Full Text] [Related]
[Next]
